Provided by Tiger Trade Technology Pte. Ltd.

FOSUN PHARMA

17.820
-0.370-2.03%
Volume:3.66M
Turnover:66.35M
Market Cap:47.19B
PE:11.99
High:18.500
Open:18.270
Low:17.800
Close:18.190
52wk High:25.915
52wk Low:14.505
Shares:2.65B
HK Float Shares:530.00M
Volume Ratio:2.02
T/O Rate:0.69%
Dividend:0.46
Dividend Rate:2.56%
EPS(LYR):1.486
ROE:6.95%
ROA:1.40%
PB:0.83
PE(LYR):11.99
PS:0.95

Loading ...

Fosun Pharma Spends HK$1.18M on Share Buyback on September 7

Stock News
·
Sep 07

Sinopharm Group Stock Rallies 0.9% in Hong Kong

Dow Jones
·
Sep 07

Fosun Pharmaceutical Extends Deadline of 81 Million Yuan Shareholder Loans to Fuyun Health; Shares Up 7%

MT Newswires Live
·
Sep 07

AI-Powered Drug Discovery Heats Up as Innovative Medicines Race Accelerates in Hong Kong Markets

Stock News
·
Sep 07

Shanghai Fosun Pharma 2196.hk Says it Plans to Buy Back up to HK$1Bln of Company H-Shares

THOMSON REUTERS
·
Sep 06

Fosun Pharma Announces HK$1.00 Billion H-Share Buyback Plan for 2026

Bulletin Express
·
Sep 06

Fosun Pharma's Unit to Trim Stake in Gland Pharma via Share Sale

Stock News
·
Sep 06

Sinopharm Group Stock Advances 1.5% in Hong Kong

Dow Jones
·
Sep 04

Fosun Pharma Receives NMPA Nod for Luvometinib’s Adult NF1 Plexiform Neurofibroma Indication

Bulletin Express
·
Sep 03

Shanghai Fosun Pharma - Drug Registration Application for Additional Indication of Luvometinib Tablets of Unit Approved by Nmpa China

THOMSON REUTERS
·
Sep 03

Shanghai Fosun Pharmaceutical Secures Regulatory Nod for Expanded Use of Lung Cancer Drug

Stock News
·
Sep 03

Regent Pacific Gets $4.5 Million Milestone Payment from Fosun Pharma Unit

MT Newswires Live
·
Sep 01

Fosun Pharma Repurchases 264,000 H Shares, Reducing Free Float by 0.05%

Bulletin Express
·
Sep 01

Fosun Pharma Spends HK$4.28 Million on Share Buyback on September 1

Stock News
·
Sep 01

Fosun Pharma Repurchases 70,500 H Shares for HKD 1.13 Million, Boosting Treasury Stock to 11.26 Million

Bulletin Express
·
Aug 31

Fosun Pharma Allocates 725,100 A-Share Options to Employees

Stock News
·
Aug 28

Fosun Pharma Grants 0.73 Million A-Share Options at RMB 27.93 Each Under 2025 Scheme

Bulletin Express
·
Aug 28

Shanghai Fosun Pharmaceutical's GR1803 Injection Gets Conditional Approval in China

MT Newswires Live
·
Aug 28

Fosun Pharma Secures Conditional NMPA Approval for GR1803 Injection

Stock News
·
Aug 27

Shanghai Fosun Pharma - Recently, Marketing Registration Application for Gr1803 Injection Has Been Approved with Conditions by Nmpa China

THOMSON REUTERS
·
Aug 27